IVS Logo in white
IVS Logo in white
Contact us
Donate

IVS Faculty Publications on Vaccine Safety

IVS Faculty Publications on Vaccine Safety

2026

  •  
  • Daniel A Salmon, Jim Buttery, Bruce Carleton, Steven Black. Toward a Brighter Future in Vaccine Safety Science: A Call For Investments, Capitalizing on Scientific Opportunities and A National Vaccine Safety Board. The Journal of Infectious Diseases, 2026. Link to Accepted Manuscript
  • Feroldi E, Mulligan MJ, Talaat KR, Tan CS, Paolino K, Edupuganti S, Collins MH, George SL, Davis M, Essink B, Jeanfreau R, Peterson J, Fried D, Minutello AM, Orlando S, Korejwo J, Rojas A, Dufournet M, Machabert T, Devlin L, Frago C; vYF Vaccine Study Team. Immunogenicity and Safety of vYF, a Yellow Fever Vaccine – A Phase 2 Trial. N Engl J Med. 2026 Apr 9;394(14):1399-1408. doi: 10.1056/NEJMoa2505665. PMID: 41950474. PubMed Abstract
  • Kallás EG, Moreira JA, Patiño EG, Braga PE, Tenório JCV, Alves LBO, Infante V, Silveira DHR, Miraglia JL, Cintra MAT, Pereira DB, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Boaventura VS, Ramos F, Júnior EE, Cassio de Moraes J, Estofolete CF, Freitas AC, Dos Santos CLS, Timenetsky MDCST, Whitehead SS, Durbin AP, Esteves-Jaramillo A, Shekar T, Lee JJ, Chen Q, Macey J, Vaidya S, Coller BG, Boulos FC, Nogueira ML, Lacerda MVG. Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine. Nat Med. 2026 Apr;32(4):1393-1400. doi: 10.1038/s41591-026-04255-3. Epub 2026 Mar 4. PMID: 41781546. PubMed Abstract
  • Odio CD, Aogo RA, Firdous S, Voirin C, Blanco-Rivera S, Lowman KE, Asante N, Broderson Y, Konda K, Hasund CM, Martinez-Perez A, Mpingabo PI, Law M, Jarvis C, Callier V, Hunsberger S, Fernandez MA, de Silva A, Kattappuram R, Bhushan G, Yek C, Manning J, Durbin AP, Cohen JI, Weiskopf D, Whitehead SS, Katzelnick LC. Enhancing, controlling, and sterilizing dengue immunity and the development of broadly protective responses. medRxiv [Preprint]. 2026 Mar 27:2026.03.26.26349424. doi: 10.64898/2026.03.26.26349424. PMID: 41929328; PMCID: PMC13042151. PubMed Abstract
  • Walter EB, Schlaudecker EP, Talaat KR, Rountree W, Broder KR, Duffy J, Montefiori D, Poniewierski MS, Spreng RL, Staat MA, Tekalign R, Museru O, Goel A, Davis GN, Schmader KE. Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trial. Vaccine. 2026 Feb 6;72:128072. doi: 10.1016/j.vaccine.2025.128072. Epub 2025 Dec 10. PMID: 41380398. PubMed Abstract
  • Schuh HB, Delamater P, Proveaux TM, Dudley MZ, Buttenheim AM, Schwartz JL, Klein NP, Goddard K, Patel KM, Omer SB, Salmon DA. In a shifting policy era: California provider knowledge and practice of medical exemption laws during the COVID-19 pandemic. Vaccine. 2026 Jan 1;69:127993. doi: 10.1016/j.vaccine.2025.127993. Epub 2025 Nov 19. PMID: 41265003; PMCID: PMC12696690. PubMed Abstract

2025

    •  
    • Garvey K, Salmon DA, Dudley MZ, Brewer J, Schuh HB. Associations between trust in public health, vaccine confidence, and COVID-19 vaccination among American adults. Vaccine. 2025 Dec 5;68:127955. doi: 10.1016/j.vaccine.2025.127955. Epub 2025 Nov 9. PMID: 41213185. PubMed Abstract
    • Kitano T, Salmon DA, Dudley MZ, Saldanha IJ, Levy JF, Austin JM, Thompson DA, Engineer L. Individual vs societal perspectives: implications on quantitative benefit-risk assessment of vaccination. Expert Rev Pharmacoecon Outcomes Res. 2025 Dec;25(10):1381-1389. doi: 10.1080/14737167.2025.2572319. Epub 2025 Oct 10. PMID: 41054401. PubMed Abstract
    • Campbell PM, Ess GJ, Lale A, Talaat KR, Barnett ED, Pelton SI, Schlaudecker EP, Staat M, Stockwell MS, LaRussa PS, Walter EB, Smith MJ, Halsey NA, Klein NP, McNeil MM, Broder KR, Shimabukuro TT, Crist MB, Fairlie TA, Sharma S, Creech CB, Edwards KM; CISA Project Team. Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviews. Vaccine. 2025 Oct 24;65:127781. doi: 10.1016/j.vaccine.2025.127781. Epub 2025 Sep 27. PMID: 41016231. PubMed Abstract
    • Barri S, Al-Dahir S, Heyer K, Taylor A, Khalil A, Belkhouche M, Bonvillain BA, Caldwell K, Surcouf H, Hamed I, Jwayyed M, Craig LS, Sarpong DF, Salmon D. Influence of respiratory disease experiences on COVID-19 vaccine acceptance: a study from Southeastern Louisiana. Front Public Health. 2025 Aug 15;13:1593861. doi: 10.3389/fpubh.2025.1593861. PMID: 40893203; PMCID: PMC12394143. PubMed Abstract
    • Jwa S, Imanishi Y, Ascher MT, Dudley MZ. Communication interventions to reduce parental vaccine hesitancy: A systematic review. Vaccine. 2025 Aug 13;61:127401. doi: 10.1016/j.vaccine.2025.127401. Epub 2025 Jun 21. PMID: 40544799. PubMed Abstract

li>Kitano T, Salmon DA, Dudley MZ, Saldanha IJ, Thompson DA, Engineer L. A Systematic Review and Meta-Analysis of Health-State Utility Values for Infectious Diseases With Pandemic Potential and Associated Vaccine Adverse Reactions. Value Health. 2025 Aug;28(8):1280-1287. doi: 10.1016/j.jval.2025.02.007. Epub 2025 Mar 4. PMID: 40049326. PubMed Abstract

  • Strother C, Bouffard N, Smolynets O, Graham NR, Elko EA, Sabundayo B, Durbin AP, Whitehead SS, Taatjes DJ, Kirkpatrick BD, Greene L, Pierce KK, Diehl SA. Localized Inflammation in Dengue Vaccine-Induced Skin Rash Is Not Associated with Continuous Presence of Dengue Virus Genome. J Invest Dermatol. 2025 Aug;145(8):2021-2033.e3. doi: 10.1016/j.jid.2024.11.015. Epub 2024 Dec 27. Erratum in: J Invest Dermatol. 2026 May;146(5):1443. doi: 10.1016/j.jid.2025.10.583. PMID: 39733933; PMCID: PMC12202709. PubMed Abstract
  • Strother C, Bouffard N, Smolynets O, Graham NR, Elko EA, Sabundayo B, Durbin AP, Whitehead SS, Taatjes DJ, Kirkpatrick BD, Greene L, Pierce KK, Diehl SA. Localized Inflammation in Dengue Vaccine-Induced Skin Rash Is Not Associated with Continuous Presence of Dengue Virus Genome. J Invest Dermatol. 2025 Aug;145(8):2021-2033.e3. doi: 10.1016/j.jid.2024.11.015. Epub 2024 Dec 27. Erratum in: J Invest Dermatol. 2026 May;146(5):1443. doi: 10.1016/j.jid.2025.10.583. PMID: 39733933; PMCID: PMC12202709. PubMed Abstract
  • Kitano T, Salmon DA, Dudley MZ, Saldanha IJ, Thompson DA, Engineer L. Age- and sex-stratified risks of myocarditis and pericarditis attributable to COVID-19 vaccination: a systematic review and meta-analysis. Epidemiol Rev. 2025 Jan 10;47(1):1-11. doi: 10.1093/epirev/mxae007. PMID: 39673764. PubMed Abstract
  • Dudley MZ, Zapf AJ, Delamater P, Proveaux TM, Schuh HB, Buttenheim AM, Schwartz JL, Klein NP, Goddard K, Patel KM, Omer SB, Salmon DA. Attitudes of California school personnel on potential COVID-19 vaccine mandates and state law SB277 to remove nonmedical vaccine exemptions. Vaccine. 2025 Feb 21;52:126888. doi: 10.1016/j.vaccine.2025.126888. PubMed Abstract
  • Jamison AM, Brewer J, Stevens A, Mowson R, Ryan V, Bobo M, Salmon DA. What Is Old Is New Again: Reimagining “The Salon” to Address Public Health Challenges. J Public Health Manag Pract. 2025 Jan-Feb 01;31(1):145-148. doi: 10.1097/PHH.0000000000002086. Epub 2024 Nov 14. PMID: 39808762. PubMed Abstract

2024

  •  
  • Strother C, Bouffard N, Smolynets O, Graham NR, Elko EA, Sabundayo B, Durbin AP, Whitehead SS, Taatjes DJ, Kirkpatrick BD, Greene L, Pierce KK, Diehl SA. Localized Inflammation in Dengue Vaccine-Induced Skin Rash Is Not Associated with Continuous Presence of Dengue Virus Genome. J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03037-9. doi: 10.1016/j.jid.2024.11.015. Epub ahead of print. PMID: 39733933. PubMed Abstract
  • Akumbom AM, Bergman AJ, Strickler H, Budhathoki C, Nkimbeng M, Grant R, Reynolds NR, Talaat KR. Understanding human papillomavirus vaccine response and efficacy in people living with HIV: A systematic mixed studies review and meta- analysis. PLOS Glob Public Health. 2024 Dec 20;4(12):e0003931. doi: 10.1371/journal.pgph.0003931. PMID: 39705286; PMCID: PMC11661617. PubMed Abstract
  • Walter EB, Schlaudecker EP, Talaat KR, Rountree W, Broder KR, Duffy J, Grohskopf LA, Poniewierski MS, Spreng RL, Staat MA, Tekalign R, Museru O, Goel A, Davis GN, Schmader KE. Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical Trial. JAMA Netw Open. 2024 Nov 4;7(11):e2443166. doi: 10.1001/jamanetworkopen.2024.43166. PMID: 39504023; PMCID: PMC11541642. PubMed Abstract
  • Al-Dahir S, Hasan TA, Khalil A, Moss WJ, Talaat KR, Knoll MD, Burnham G. Changes in healthcare seeking behaviors among caretakers of children in the previously occupied ISIS territory: Hadeetha, Anbar, Iraq: a cross-sectional survey of 415 households. Confl Health. 2024 Oct 21;18(1):64. doi: 10.1186/s13031-024-00622-4. PMID: 39434165; PMCID: PMC11495094. PubMed Abstract
  • Schmader KE, Walter EB, Talaat KR, Rountree W, Poniewierski M, Randolph E, Leng SX, Wunderlich B, McNeil MM, Museru O, Broder KR. Safety of Simultaneous Vaccination With Adjuvanted Zoster Vaccine and Adjuvanted Influenza Vaccine: A Randomized Clinical Trial. JAMA Netw Open. 2024 Oct 1;7(10):e2440817. doi: 10.1001/jamanetworkopen.2024.40817. PMID: 39446325; PMCID: PMC11581605. PubMed Abstract
  • Sher LD, Boakye-Appiah JK, Hill S, Wasserman E, Xu X, Maldonado Y, Walter EB, Muñoz FM, Paulsen GC, Englund JA, Talaat KR, Barnett ED, Kamidani S, Senders S, Simões EAF, Belanger K, Parikh V, Ma H, Wang X, Lu C, Cooper D, Koury K, Anderson AS, Türeci Ö, Şahin U, Swanson KA, Gruber WC, Gurtman A, Kitchin N, Sabharwal C. Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds. J Pediatric Infect Dis Soc. 2024 Aug 24;13(8):421-429. doi: 10.1093/jpids/piae062. PMID: 38860591; PMCID: PMC11344470. PubMed Abstract
  • Salmon DA, Orenstein WA, Plotkin SA, Chen RT. Funding Postauthorization Vaccine-Safety Science. N Engl J Med. 2024 Jul 11;391(2):102-105. doi: 10.1056/NEJMp2402379. Epub 2024 Jul 6. PMID: 38973739. PubMed Abstract | Commentary on this article available here
  • Zapf AJ, Schuh HB, Dudley MZ, Rimal RN, Harvey SA, Shaw J, Balgobin K, Salmon DA. Knowledge, attitudes, and intentions regarding COVID-19 vaccination in the general population and the effect of different framing messages for a brief video on intentions to get vaccinated among unvaccinated individuals in the United States during July 2021. Patient Educ Couns. 2024 Jul;124:108258. doi: 10.1016/j.pec.2024.108258. Epub 2024 Mar 26. PMID: 38608538. PubMed Abstract
  • Kitano T, Dudley MZ, Engineer L, Thompson DA, Salmon DA. The authors reply to Kurita et al and Lataster. Am J Epidemiol. 2024 Jun 3;193(6):932-934. doi: 10.1093/aje/kwad243. PMID: 38115177. PubMed Abstract
  • Ritter KE, Durbin AD. Lineage-Selective Dependencies in Pediatric Cancers. Cold Spring Harb Perspect Med. 2024 May 28:a041573. doi: 10.1101/cshperspect.a041573. Epub ahead of print. PMID: 38806246. PubMed Abstract
  • Fisher LH, Kee JJ, Liu A, Espinosa CM, Randhawa AK, Ludwig J, Magaret CA, Robinson ST, Gilbert PB, Hyrien O, Kublin JG, Rouphael N, Falsey AR, Sobieszczyk ME, El Sahly HM, Grinsztejn B, Gray GE, Kotloff KL, Gay CL, Leav B, Hirsch I, Struyf F, Dunkle LM, Neuzil KM, Corey L, Huang Y, Goepfert PA, Walsh SR, Baden LR, Janes H; COVID-19 Prevention Network (CoVPN). SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials. JAMA Netw Open. 2024 May 1;7(5):e2412835. doi: 10.1001/jamanetworkopen.2024.12835. PMID: 38780941; PMCID: PMC11117088. PubMed Abstract
  • Talaat KR, Porter CK, Chakraborty S, Feijoo BL, Brubaker J, Adjoodani BM, DeNearing B, Prouty MG, Poole ST, Bourgeois AL, Billingsley M, Sack DA, Eder- Lingelbach S, Taucher C. Validation of a Human Challenge Model Using an LT- Expressing Enterotoxigenic E. coli Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701). Microorganisms. 2024 Apr 3;12(4):727. doi: 10.3390/microorganisms12040727. PMID: 38674674; PMCID: PMC11051778. PubMed Abstract
  • Pierce KK, Durbin AP, Walsh MR, Carmolli M, Sabundayo BP, Dickson DM, Diehl SA, Whitehead SS, Kirkpatrick BD. TV005 dengue vaccine protects against dengue serotypes 2 and 3 in two controlled human infection studies. J Clin Invest. 2024 Feb 1;134(3):e173328. doi: 10.1172/JCI173328. PMID: 37971871; PMCID: PMC10836801. PubMed Abstract
  • Walsh MR, Alam MS, Pierce KK, Carmolli M, Alam M, Dickson DM, Bak DM, Afreen S, Nazib F, Golam K, Qadri F, Diehl SA, Durbin AP, Whitehead SS, Haque R, Kirkpatrick BD. Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial. Lancet Infect Dis. 2024 Feb;24(2):150-160. doi: 10.1016/S1473-3099(23)00520-0. Epub 2023 Sep 27. PMID: 37776876; PMCID: PMC11267251. PubMed Abstract
  • Pierce KK, Whitehead SS, Diehl SA, Naro G, Carmolli MC, He H, Tibery CM, Sabundayo BP, Kirkpatrick BD, Durbin AP. Evaluation of a new dengue 3 controlled human infection model for use in the evaluation of candidate dengue vaccines. medRxiv [Preprint]. 2024 Jan 26:2023.06.07.23291100. doi: 10.1101/2023.06.07.23291100. PMID: 37790382; PMCID: PMC10543052. PubMed Abstract
  • Powell TW, Forr A, Johnson S, Clinton T, Gaither J, Brewer J, Dudley MZ, Holifield J, Wilson P, Benson LR, Harr L, Salmon DA, Mendelson T. The Voices on Vax Campaign: Lessons Learned from Engaging Youth to Promote COVID Vaccination. Prog Community Health Partners. 2024;18(3):345-353. PMID: 39308378. PubMed Abstract
  • Clarkson KA, Porter CK, Talaat KR, Kapulu MC, Chen WH, Frenck RW Jr, Bourgeois AL, Kaminski RW, Martin LB. Shigella-Controlled Human Infection Models: Current and Future Perspectives. Curr Top Microbiol Immunol. 2024;445:257-313. doi: 10.1007/82_2021_248. PMID: 35616717; PMCID: PMC7616482. PubMed Abstract
  • Porter CK, Talaat KR, Isidean SD, Kardinaal A, Chakraborty S, Gutiérrez RL, Sack DA, Bourgeois AL. The Controlled Human Infection Model for Enterotoxigenic Escherichia coli. Curr Top Microbiol Immunol. 2024;445:189-228. doi: 10.1007/82_2021_242. PMID: 34669040. PubMed AbstractDudley MZ, Schuh HB, Forr A, Shaw J, Salmon DA. Changes in vaccine attitudes and recommendations among US Healthcare Personnel during the COVID-19 pandemic. NPJ Vaccines. 2024 Feb 28;9(1):49. doi: 10.1038/s41541-024-00826-y. PMID: 38418562; PMCID: PMC10901873. PubMed Abstract
  • Kitano T, Salmon DA, Dudley MZ, Thompson DA, Engineer L. Benefit-Risk Assessment of mRNA COVID-19 Vaccines in Children Aged 6 Months to 4 Years in the Omicron Era. J Pediatric Infect Dis Soc. 2024 Feb 26;13(2):129-135. doi: 10.1093/jpids/piae002. PMID: 38236136. PubMed Abstract
  • Kapulu M, Manda-Taylor L, Balasingam S, Means G, Ayiro Malungu M, Bejon P, Chi PC, Chiu C, Church EC, Correa-Oliveira R, Day N, Durbin A, Egesa M, Emerson C, Jambo K, Mathur R, Metzger W, Mumba N, Nazziwa W, Olotu A, Rodgers J, Sinyiza F, Talaat K, Kamerling I, Weller C, Baay M, Neels P. Fourth Controlled Human Infection Model (CHIM) meeting – CHIMs in endemic countries, May 22-23, 2023. Biologicals. 2024 Feb 12:101747. doi: 10.1016/j.biologicals.2024.101747. Epub ahead of print. PMID: 38350825. PubMed Abstract
  • Cavaleri M, Kaslow D, Boateng E, Chen WH, Chiu C, Choy RKM, Correa-Oliveira R, Durbin A, Egesa M, Gibani M, Kapulu M, Katindi M, Olotu A, Pongsuwan P, Simuyandi M, Speder B, Talaat KR, Weller C, Wills B, Baay M, Balasingam S, Olesen OF, Neels P. Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023. Biologicals. 2024 Feb 10:101745. doi: 10.1016/j.biologicals.2024.101745. Epub ahead of print. PMID: 38341355. PubMed Abstract
  • Corti N, Chiu C, Cox RJ, Demont C, Devaster JM, Engelhardt OG, Gorringe A, Hassan K, Hoefnagel M, Kamerling I, Krut O, Lane C, Liebers R, Luke C, Van Molle W, Morel S, Neels P, Roestenberg M, Rubbrecht M, Klaas Smits W, Stoughton D, Talaat K, Vehreschild MJGT, Wildfire A, Meln I, Olesen OF. Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report. Biologicals. 2024 Feb 2:101746. doi: 10.1016/j.biologicals.2024.101746. Epub ahead of print. PMID: 38309984. PubMed Abstract
  • Salmon DA, Chen RT, Black S, Sharfstein J. Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States: a path to a more robust vaccine safety program. Expert Opin Drug Saf. 2024 Feb;23(2):161-175. doi: 10.1080/14740338.2024.2305707. Epub 2024 Feb 11. PMID: 38343204. PubMed Abstract
  • Gutiérrez RL, Porter CK, Harro C, Talaat K, Riddle MS, DeNearing B, Brubaker J, Maciel M Jr, Laird RM, Poole S, Chakraborty S, Maier N, Sack DA, Savarino SJ. Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic Escherichia coli CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic E. coli H10407 in Healthy Adult Volunteers. Microorganisms. 2024 Jan 29;12(2):288. doi: 10.3390/microorganisms12020288. PMID: 38399692; PMCID: PMC10892241. PubMed Abstract

2023

  •  
  • Schwartz B, Brewer J, Budigan H, Bernier R, Dudley MZ, Kan L, Proveaux TM, Roberts R, Tafoya N, Hamlin MD, Moore L, Hughes M, Turner B, Al-Dahir S, Velasco E, Privor-Dumm L, Veloz W, White JA, Dubois S, Ooton J, Kipp BJ, Show TJ, Salu K, Chavez B, Montes MDP, Najera R, King T, Salmon DA. Factors Affecting SARS-CoV-2 Vaccination Intent and Decision Making Among African American, Native American, and Hispanic Participants in a Qualitative Study. Public Health Rep 2023: 333549231160871. PubMed Abstract.
  • Salmon DA, Plotkin S, Navar AM. Vaccine Decision-making in a Time of Conflicting Recommendations: A Call to Go Beyond Politics. Pediatr Infect Dis J 2023. PubMed Abstract.
  • Opel DJ, Brewer NT, Buttenheim AM, Callaghan T, Carpiano RM, Clinton C, Elharake JA, Flowers LC, Galvani AP, Hotez PJ, Schwartz JL, Benjamin RM, Caplan A, DiResta R, Lakshmanan R, Maldonado YA, Mello MM, Parmet WE, Salmon DA, Sharfstein JM, Omer SB. The legacy of the COVID-19 pandemic for childhood vaccination in the USA. Lancet 2023; 401(10370): 75-8. PubMed Abstract.
  • Muñoz FM, Sher LD, Sabharwal C, Gurtman A, Xu X, Kitchin N, Lockhart S, Riesenberg R, Sexter JM, Czajka H, Paulsen GC, Maldonado Y, Walter EB, Talaat KR, Englund JA, Sarwar UN, Hansen C, Iwamoto M, Webber C, Cunliffe L, Ukkonen B, Martínez SN, Pahud BA, Munjal I, Domachowske JB, Swanson KA, Ma H, Koury K, Mather S, Lu C, Zou J, Xie X, Shi PY, Cooper D, Türeci Ö, Şahin U, Jansen KU, Gruber WC. Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age. N Engl J Med 2023; 388(7): 621-34. PubMed Abstract.
  • Lynch JA, Lim JK, Asaga PEP, Wartel TA, Marti M, Yakubu B, Rees H, Talaat K, Kmush B, Aggarwal R, Ciglenecki I, Gurley E, Labrique AB. Hepatitis E vaccine-Illuminating the barriers to use. PLoS Negl Trop Dis 2023; 17(1): e0010969. PubMed Abstract.
  • Kitano T, Thompson DA, Engineer L, Dudley M, Salmon DA. Risk and benefit of mRNA COVID-19 vaccines for Omicron variant by age, sex and presence of comorbidity: a quality-adjusted life years analysis. Am J Epidemiol 2023. PubMed Abstract.
  • Dudley MZ, Schuh HB, Shaw J, Rimal RN, Harvey SA, Balgobin KR, Zapf AJ, Salmon DA. COVID-19 vaccination among different types of US Healthcare Personnel. Vaccine 2023; 41(8): 1471-9. PubMed Abstract.
  • Dudley MZ, Gerber JE, Budigan Ni H, Blunt M, Holroyd TA, Carleton BC, Poland GA, Salmon DA. Vaccinomics: A scoping review. Vaccine 2023; 41(14): 2357-67. PubMed Abstract.
  • Dudley MZ, Barnett EE, Paulenich A, Omer SB, Schuh H, Proveaux TM, Buttenheim AM, Klein NP, Delamater P, McFadden SM, Patel KM, Salmon DA. Characterization of parental intention to vaccinate elementary school aged children in the state of California. Vaccine 2023; 41(3): 630-5. PubMed Abstract.
  • Carpiano RM, Callaghan T, DiResta R, Brewer NT, Clinton C, Galvani AP, Lakshmanan R, Parmet WE, Omer SB, Buttenheim AM, Benjamin RM, Caplan A, Elharake JA, Flowers LC, Maldonado YA, Mello MM, Opel DJ, Salmon DA, Schwartz JL, Sharfstein JM, Hotez PJ. Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era. Lancet 2023; 401(10380): 967-70. PubMed Abstract.
  • Budigan Ni H, de Broucker G, Patenaude BN, Dudley MZ, Hampton LM, Salmon DA. Economic impact of vaccine safety incident in Ukraine: The economic case for safety system investment. Vaccine 2023; 41(1): 219-25. PubMed Abstract.
  • Bollinger JM, Geller G, May E, Brewer J, Henry LM, Sugarman J. Challenges in Obtaining the Informed Perspectives of Stakeholders regarding HIV Molecular Epidemiology. J Acquir Immune Defic Syndr 2023. PubMed Abstract.

2022

  •  
  • Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, Barnett ED, Muñoz FM, Maldonado Y, Pahud BA, Domachowske JB, Simões EAF, Sarwar UN, Kitchin N, Cunliffe L, Rojo P, Kuchar E, Rämet M, Munjal I, Perez JL, Frenck RW, Jr., Lagkadinou E, Swanson KA, Ma H, Xu X, Koury K, Mather S, Belanger TJ, Cooper D, Türeci Ö, Dormitzer PR, Şahin U, Jansen KU, Gruber WC. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. N Engl J Med 2022; 386(1): 35-46. PubMed Abstract.
  • Walter EB, Talaat KR, Gurtman A. BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply. N Engl J Med 2022; 386(6): 606. PubMed Abstract.
  • Walter EB, Talaat KR, Gurtman A. More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply. N Engl J Med 2022; 386(12): 1192-3. PubMed Abstract.
  • Trent MJ, Salmon DA, MacIntyre CR. Predictors of pneumococcal vaccination among Australian adults at high risk of pneumococcal disease. Vaccine 2022; 40(8): 1152-61. PubMed Abstract.
  • Shaw J, Hanley S, Stewart T, Salmon DA, Ortiz C, Trief PM, Asiago Reddy E, Morley CP, Thomas SJ, Anderson KB. Healthcare Personnel (HCP) Attitudes About Coronavirus Disease 2019 (COVID-19) Vaccination After Emergency Use Authorization. Clin Infect Dis 2022; 75(1): e814-e21. PubMed Abstract.
  • See I, Lale A, Marquez P, Streiff MB, Wheeler AP, Tepper NK, Woo EJ, Broder KR, Edwards KM, Gallego R, Geller AI, Jackson KA, Sharma S, Talaat KR, Walter EB, Akpan IJ, Ortel TL, Urrutia VC, Walker SC, Yui JC, Shimabukuro TT, Mba-Jonas A, Su JR, Shay DK. Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021. Ann Intern Med 2022; 175(4): 513-22. PubMed Abstract.
  • Sargent RH, Laurie S, Weakland LF, Lavery JV, Salmon DA, Orenstein WA, Breiman RF. Use of Random Domain Intercept Technology to Track COVID-19 Vaccination Rates in Real Time Across the United States: Survey Study. J Med Internet Res 2022; 24(7): e37920. PubMed Abstract.
  • Sargent RH, Laurie S, Moncada L, Weakland LF, Lavery JV, Salmon DA, Orenstein WA, Breiman RF. Masks, money, and mandates: A national survey on efforts to increase COVID-19 vaccination intentions in the United States. PLoS One 2022; 17(4): e0267154. PubMed Abstract.
  • Salmon DA, Schuh HB, Sargent RH, Konja A, Harvey SA, Laurie S, Mai BS, Weakland LF, Lavery JV, Orenstein WA, Breiman RF. Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population. PLoS One 2022; 17(10): e0274443. PubMed Abstract.
  • Salmon DA, Elharake JA, Brewer NT, Carpiano RM, DiResta R, Maldonado YA, Sgaier SK, Omer SB. Vaccine Verification in the COVID-19 World. Lancet Reg Health Am 2022; 6: 100161. PubMed Abstract.
  • Salmon DA, Black S, Didierlaurent AM, Moulton LH. Commentary on “Common vaccines and the risk of dementia: a population-based cohort study”: Science can be messy but eventually leads to truths. J Infect Dis 2022. PubMed Abstract.
  • Porter CK, Detizio KJ, Maier N, Testa KJ, Talaat KR, Chen WH, Lyon CE, Gutierrez RL, Frenck R, Isidean SD, Kaminski RW, Alcala AN, Hanevik K, Sawe F, Kirkpatrick BD, Louis Bourgeois A. A site assessment tool for inpatient controlled human infection models for enteric disease pathogens. Clin Trials 2022; 19(1): 116-8. PubMed Abstract.
  • Patel KM, McFadden SM, Mohanty S, Joyce CM, Delamater PL, Klein NP, Salmon DA, Omer SB, Buttenheim AM. Evaluation of Trends in Homeschooling Rates After Elimination of Nonmedical Exemptions to Childhood Immunizations in California, 2012-2020. JAMA Netw Open 2022; 5(2): e2146467. PubMed Abstract.
  • Omer SB, O’Leary ST, Bednarczyk RA, Ellingson MK, Spina CI, Dudley MZ, Chamberlain AT, Limaye RJ, Brewer SE, Frew PM, Malik FA, Orenstein W, Halsey N, Ault K, Salmon DA. Multi-tiered intervention to increase maternal immunization coverage: A randomized, controlled trial. Vaccine 2022; 40(34): 4955-63. PubMed Abstract.
  • Moreira ED, Jr., Kitchin N, Xu X, Dychter SS, Lockhart S, Gurtman A, Perez JL, Zerbini C, Dever ME, Jennings TW, Brandon DM, Cannon KD, Koren MJ, Denham DS, Berhe M, Fitz-Patrick D, Hammitt LL, Klein NP, Nell H, Keep G, Wang X, Koury K, Swanson KA, Cooper D, Lu C, Türeci Ö, Lagkadinou E, Tresnan DB, Dormitzer PR, Şahin U, Gruber WC, Jansen KU. Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine. N Engl J Med 2022; 386(20): 1910-21. PubMed Abstract.
  • Mello MM, Opel DJ, Benjamin RM, Callaghan T, DiResta R, Elharake JA, Flowers LC, Galvani AP, Salmon DA, Schwartz JL, Brewer NT, Buttenheim AM, Carpiano RM, Clinton C, Hotez PJ, Lakshmanan R, Maldonado YA, Omer SB, Sharfstein JM, Caplan A. Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA. Lancet 2022; 400(10351): 535-8. PubMed Abstract.
  • Mantua J, Gutierrez RL, Isidean SD, Alcala AN, Testa KJ, Talaat KR, Doty TJ, Porter CK. Sleep duration prior to an enterotoxigenic Escherichia coli challenge predicts diarrhea severity during infection. Sleep Med 2022; 100: 404-9. PubMed Abstract.
  • MacLennan CA, Talaat KR, Kaminski RW, Cohen D, Riddle MS, Giersing BK. Critical Needs in Advancing Shigella Vaccines for Global Health. J Infect Dis 2022; 225(9): 1500-3. PubMed Abstract.
  • Dudley MZ, Schwartz B, Brewer J, Kan L, Bernier R, Gerber JE, Ni HB, Proveaux TM, Rimal RN, Salmon DA. COVID-19 Vaccination Status, Attitudes, and Values among US Adults in September 2021. J Clin Med 2022; 11(13). PubMed Abstract.
  • Dudley MZ, Omer SB, O’Leary ST, Limaye RJ, Ellingson MK, Spina CI, Brewer SE, Bednarczyk RA, Chamberlain AT, Malik F, Frew PM, Church-Balin C, Riley LE, Ault KA, Orenstein WA, Halsey NA, Salmon DA. MomsTalkShots, tailored educational app, improves vaccine attitudes: a randomized controlled trial. BMC Public Health 2022; 22(1): 2134. PubMed Abstract.
  • Clarkson KA, Porter CK, Talaat KR, Kapulu MC, Chen WH, Frenck RW, Jr., Bourgeois AL, Kaminski RW, Martin LB. Shigella-Controlled Human Infection Models: Current and Future Perspectives. Curr Top Microbiol Immunol 2022. PubMed Abstract.
  • Brewer NT, Buttenheim AM, Clinton CV, Mello MM, Benjamin RM, Callaghan T, Caplan A, Carpiano RM, DiResta R, Elharake JA, Flowers LC, Galvani AP, Hotez PJ, Lakshmanan R, Maldonado YA, Omer SB, Salmon DA, Schwartz JL, Sharfstein JM, Opel DJ. Incentives for COVID-19 vaccination. Lancet Reg Health Am 2022; 8: 100205. PubMed Abstract.
  • Belay ED, Godfred Cato S, Rao AK, Abrams J, Wyatt Wilson W, Lim S, Newton-Cheh C, Melgar M, DeCuir J, Webb B, Marquez P, Su JR, Meng L, Grome HN, Schlaudecker E, Talaat K, Edwards K, Barnett E, Campbell AP, Broder KR, Bamrah Morris S. Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination. Clin Infect Dis 2022; 75(1): e741-e8. PubMed Abstract.

2021

  •  
  • Wu Q, Dudley MZ, Chen X, Bai X, Dong K, Zhuang T, Salmon D, Yu H. Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC Med 2021; 19(1): 173. PubMed Abstract.
  • Ware JM, O’Connell EM, Brown T, Wetzler L, Talaat KR, Nutman TB, Nash TE. Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis. Clin Infect Dis 2021; 73(7): e2457-e562. PubMed Abstract.
  • Trent MJ, Salmon DA, MacIntyre CR. Using the health belief model to identify barriers to seasonal influenza vaccination among Australian adults in 2019. Influenza Other Respir Viruses 2021; 15(5): 678-87. PubMed Abstract.
  • Trent MJ, Salmon DA, MacIntyre CR. Pharmacy, workplace or primary care? Where Australian adults get their influenza vaccines. Aust N Z J Public Health 2021; 45(4): 385-90. PubMed Abstract.
  • Thomas SJ, Moreira ED, Jr., Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Polack FP, Zerbini C, Bailey R, Swanson KA, Xu X, Roychoudhury S, Koury K, Bouguermouh S, Kalina WV, Cooper D, Frenck RW, Jr., Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Yang Q, Liberator P, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Gruber WC, Jansen KU. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. N Engl J Med 2021; 385(19): 1761-73. PubMed Abstract.
  • Talaat KR, Alaimo C, Martin P, Bourgeois AL, Dreyer AM, Kaminski RW, Porter CK, Chakraborty S, Clarkson KA, Brubaker J, Elwood D, Frölich R, DeNearing B, Weerts H, Feijoo BL, Halpern J, Sack D, Riddle MS, Fonck VG. Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection. EBioMedicine 2021; 66: 103310. PubMed Abstract.
  • Talaat K, Hecht A, Xi J. A comparison of CFPD, compartment, and uniform distribution models for radiation dosimetry of radionuclides in the lung. J Radiol Prot 2021; 41(4). PubMed Abstract.
  • Talaat K, Fathi OT, Alamoudi SM, Alzahrani MG, Mukhtar RM, Khan MA. Types of Glaucoma and Associated Comorbidities Among Patients at King Abdulaziz Medical City, Jeddah. Cureus 2021; 13(6): e15574. PubMed Abstract.
  • Talaat K, Abuhegazy M, Mahfoze OA, Anderoglu O, Poroseva SV. Simulation of aerosol transmission on a Boeing 737 airplane with intervention measures for COVID-19 mitigation. Phys Fluids (1994) 2021; 33(3): 033312. PubMed Abstract.
  • Stamps BW, Kuroiwa J, Isidean SD, Schilling MA, Harro C, Talaat KR, Sack DA, Tribble DR, Maue AC, Rimmer JE, Laird RM, Porter CK, Goodson MS, Poly F. Exploring Changes in the Host Gut Microbiota During a Controlled Human Infection Model for Campylobacter jejuni. Front Cell Infect Microbiol 2021; 11: 702047. PubMed Abstract.
  • Shaw J, Stewart T, Anderson KB, Hanley S, Thomas SJ, Salmon DA, Morley C. Assessment of US Healthcare Personnel Attitudes Towards Coronavirus Disease 2019 (COVID-19) Vaccination in a Large University Healthcare System. Clin Infect Dis 2021; 73(10): 1776-83. PubMed Abstract.
  • Sharfstein JM, Callaghan T, Carpiano RM, Sgaier SK, Brewer NT, Galvani AP, Lakshmanan R, McFadden SM, Reiss DR, Salmon DA, Hotez PJ. Uncoupling vaccination from politics: a call to action. Lancet 2021; 398(10307): 1211-2. PubMed Abstract.
  • See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT, Streiff MB, Rao AK, Wheeler AP, Beavers SF, Durbin AP, Edwards K, Miller E, Harrington TA, Mba-Jonas A, Nair N, Nguyen DT, Talaat KR, Urrutia VC, Walker SC, Creech CB, Clark TA, DeStefano F, Broder KR. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. Jama 2021; 325(24): 2448-56. PubMed Abstract.
  • Schoch-Spana M, Brunson EK, Long R, Ruth A, Ravi SJ, Trotochaud M, Borio L, Brewer J, Buccina J, Connell N, Hall LL, Kass N, Kirkland A, Koonin L, Larson H, Lu BF, Omer SB, Orenstein WA, Poland GA, Privor-Dumm L, Quinn SC, Salmon D, White A. The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine 2021; 39(40): 6004-12. PubMed Abstract.
  • Salmon DA, Lambert PH, Nohynek HM, Gee J, Parashar UD, Tate JE, Wilder-Smith A, Hartigan-Go KY, Smith PG, Zuber PLF. Novel vaccine safety issues and areas that would benefit from further research. BMJ Glob Health 2021; 6(Suppl 2). PubMed Abstract.
  • Salmon DA, Dudley MZ, Carleton BC. Guillain-Barré Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence. J Infect Dis 2021; 223(3): 355-8. PubMed Abstract.
  • Salmon DA, Dudley MZ, Brewer J, Kan L, Gerber JE, Budigan H, Proveaux TM, Bernier R, Rimal R, Schwartz B. COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization. Vaccine 2021; 39(19): 2698-711. PubMed Abstract.
  • Salmon D, Opel DJ, Dudley MZ, Brewer J, Breiman R. Reflections On Governance, Communication, And Equity: Challenges And Opportunities In COVID-19 Vaccination. Health Aff (Millwood) 2021; 40(3): 419-25. PubMed Abstract.
  • Porter CK, Talaat KR, Isidean SD, Kardinaal A, Chakraborty S, Gutiérrez RL, Sack DA, Bourgeois AL. The Controlled Human Infection Model for Enterotoxigenic Escherichia coli. Curr Top Microbiol Immunol 2021. PubMed Abstract.
  • Omer SB, Benjamin RM, Brewer NT, Buttenheim AM, Callaghan T, Caplan A, Carpiano RM, Clinton C, DiResta R, Elharake JA, Flowers LC, Galvani AP, Lakshmanan R, Maldonado YA, McFadden SM, Mello MM, Opel DJ, Reiss DR, Salmon DA, Schwartz JL, Sharfstein JM, Hotez PJ. Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. Lancet 2021; 398(10317): 2186-92. PubMed Abstract.
  • Munoz FM, Cramer JP, Dekker CL, Dudley MZ, Graham BS, Gurwith M, Law B, Perlman S, Polack FP, Spergel JM, Van Braeckel E, Ward BJ, Didierlaurent AM, Lambert PH. Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2021; 39(22): 3053-66. PubMed Abstract.
  • Limaye RJ, Opel DJ, Dempsey A, Ellingson M, Spina C, Omer SB, Dudley MZ, Salmon DA, Leary SO. Communicating With Vaccine-Hesitant Parents: A Narrative Review. Acad Pediatr 2021; 21(4s): S24-s9. PubMed Abstract.
  • Holroyd TA, Limaye RJ, Gerber JE, Rimal RN, Musci RJ, Brewer J, Sutherland A, Blunt M, Geller G, Salmon DA. Development of a Scale to Measure Trust in Public Health Authorities: Prevalence of Trust and Association with Vaccination. J Health Commun 2021; 26(4): 272-80. PubMed Abstract.
  • Holroyd TA, Howa AC, Proveaux TM, Delamater PL, Klein NP, Buttenheim AM, Limaye RJ, Omer SB, Salmon DA. School-level perceptions and enforcement of the elimination of nonmedical exemptions to vaccination in California. Hum Vaccin Immunother 2021; 17(7): 1986-93. PubMed Abstract.
  • Holroyd TA, Howa AC, Delamater PL, Klein NP, Buttenheim AM, Limaye RJ, Proveaux TM, Omer SB, Salmon DA. Parental vaccine attitudes, beliefs, and practices: initial evidence in California after a vaccine policy change. Hum Vaccin Immunother 2021; 17(6): 1675-80. PubMed Abstract.
  • Gostin LO, Shaw J, Salmon DA. Mandatory SARS-CoV-2 Vaccinations in K-12 Schools, Colleges/Universities, and Businesses. Jama 2021; 326(1): 25-6. PubMed Abstract.
  • Gostin LO, Salmon DA, Larson HJ. Mandating COVID-19 Vaccines. Jama 2021; 325(6): 532-3. PubMed Abstract.
  • Gerber JE, Brewer J, Limaye RJ, Sutherland A, Geller G, Spina CI, Salmon DA. Ethical and policy implications of vaccinomics in the United States: community members’ perspectives. Hum Vaccin Immunother 2021; 17(7): 2133-44. PubMed Abstract.
  • Gerber JE, Brewer J, Limaye RJ, Sutherland A, Blunt M, Holroyd TA, Geller G, Carleton B, Kahn J, Salmon DA. Vaccinomics: a cross-sectional survey of public values. Hum Vaccin Immunother 2021; 17(9): 2999-3015. PubMed Abstract.
  • Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A, Pickrell P, Daar ES, Bush L, Solis J, Carr QO, Oyedele T, Buchbinder S, Cowden J, Vargas SL, Guerreros Benavides A, Call R, Keefer MC, Kirkpatrick BD, Pullman J, Tong T, Brewinski Isaacs M, Benkeser D, Janes HE, Nason MC, Green JA, Kelly EJ, Maaske J, Mueller N, Shoemaker K, Takas T, Marshall RP, Pangalos MN, Villafana T, Gonzalez-Lopez A. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. N Engl J Med 2021; 385(25): 2348-60. PubMed Abstract.
  • Dudley MZ, Taitel MS, Smith-Ray R, Singh T, Limaye RJ, Salmon DA. Effect of educational and financial incentive-based interventions on immunization attitudes, beliefs, intentions and receipt among close contacts of pregnant women. Vaccine 2021; 39(6): 961-7. PubMed Abstract.
  • Dudley MZ, Limaye RJ, Salmon DA, Omer SB, O’Leary ST, Ellingson MK, Spina CI, Brewer SE, Bednarczyk RA, Malik F, Frew PM, Chamberlain AT. Racial/Ethnic Disparities in Maternal Vaccine Knowledge, Attitudes, and Intentions. Public Health Rep 2021; 136(6): 699-709. PubMed Abstract.
  • Dudley MZ, Bernier R, Brewer J, Salmon DA. Walking the Tightrope: Reevaluating science communication in the era of COVID-19 vaccines. Vaccine 2021; 39(39): 5453-5. PubMed Abstract.
  • Clarkson KA, Talaat KR, Alaimo C, Martin P, Bourgeois AL, Dreyer A, Porter CK, Chakraborty S, Brubaker J, Elwood D, Frölich R, DeNearing B, Weerts HP, Feijoo B, Halpern J, Sack D, Riddle MS, Fonck VG, Kaminski RW. Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine. EBioMedicine 2021; 66: 103308. PubMed Abstract.
  • Clarkson KA, Porter CK, Talaat KR, Frenck RW, Jr., Alaimo C, Martin P, Bourgeois AL, Kaminski RW. Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei. mSphere 2021; 6(4): e0012221. PubMed Abstract.
  • Castro-Sesquen YE, Tinajeros F, Bern C, Galdos-Cardenas G, Malaga ES, Valencia Ayala E, Hjerrild K, Clipman SJ, Lescano AG, Bayangos T, Castillo W, Menduiña MC, Talaat KR, Gilman RH. The Immunoglobulin M-Shed Acute Phase Antigen (SAPA)-test for the Early Diagnosis of Congenital Chagas Disease in the Time of the Elimination Goal of Mother-to-Child Transmission. Clin Infect Dis 2021; 73(2): e477-e84. PubMed Abstract.
  • Castro-Sesquen YE, Saldaña A, Patino Nava D, Paulette Evans D, Bayangos T, DeToy K, Trevino A, Marcus R, Bern C, Gilman RH, Talaat KR. Evaluation of 2 Lateral Flow Rapid Tests in the Diagnosis of Chagas Disease in the Washington Metropolitan Area. Open Forum Infect Dis 2021; 8(4): ofab096. PubMed Abstract.
  • Castro-Sesquen YE, Saldaña A, Patino Nava D, Bayangos T, Paulette Evans D, DeToy K, Trevino A, Marcus R, Bern C, Gilman RH, Talaat KR. Use of a Latent Class Analysis in the Diagnosis of Chronic Chagas Disease in the Washington Metropolitan Area. Clin Infect Dis 2021; 72(9): e303-e10. PubMed Abstract.
  • Announcing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. Lancet 2021; 397(10280): 1165-7. PubMed Abstract.

2020

  •  
  • Vakamudi K, Trapp C, Talaat K, Gao K, Sa De La Rocque Guimaraes B, Posse S. Real-Time Resting-State Functional Magnetic Resonance Imaging Using Averaged Sliding Windows with Partial Correlations and Regression of Confounding Signals. Brain Connect 2020; 10(8): 448-63. PubMed Abstract.
  • Talaat KR, Porter CK, Jaep KM, Duplessis CA, Gutierrez RL, Maciel M, Jr., Adjoodani B, Feijoo B, Chakraborty S, Brubaker J, Trop SA, Riddle MS, Joseph SS, Bourgeois AL, Prouty MG. Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial. PLoS One 2020; 15(12): e0239888. PubMed Abstract.
  • Talaat KR, Porter CK, Bourgeois AL, Lee TK, Duplessis CA, Maciel M, Jr., Gutierrez RL, DeNearing B, Adjoodani B, Adkinson R, Testa KJ, Feijoo B, Alcala AN, Brubaker J, Beselman A, Chakraborty S, Sack D, Halpern J, Trop S, Wu H, Jiao J, Sullivan E, Riddle MS, Joseph SS, Poole ST, Prouty MG. Oral delivery of Hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic Escherichia coli as a prophylactic against diarrhea. Gut Microbes 2020; 12(1): 1732852. PubMed Abstract.
  • Spina CI, Brewer SE, Ellingson MK, Chamberlain AT, Limaye RJ, Orenstein WA, Salmon DA, Omer SB, O’Leary ST. Adapting Center for Disease Control and Prevention’s immunization quality improvement program to improve maternal vaccination uptake in obstetrics. Vaccine 2020; 38(50): 7963-9. PubMed Abstract.
  • Salmon DA, Dudley MZ. It is time to get serious about vaccine confidence. Lancet 2020; 396(10255): 870-1. PubMed Abstract.
  • Opel DJ, Salmon DA, Marcuse EK. Building Trust to Achieve Confidence in COVID-19 Vaccines. JAMA Netw Open 2020; 3(10): e2025672. PubMed Abstract.
  • Limaye RJ, Malik F, Frew PM, Randall LA, Ellingson MK, O’Leary ST, Bednarczyk RA, Oloko O, Salmon DA, Omer SB. Patient Decision Making Related to Maternal and Childhood Vaccines: Exploring the Role of Trust in Providers Through a Relational Theory of Power Approach. Health Educ Behav 2020; 47(3): 449-56. PubMed Abstract.
  • Kochhar S, Salmon DA. Planning for COVID-19 vaccines safety surveillance. Vaccine 2020; 38(40): 6194-8. PubMed Abstract.
  • Holroyd TA, Oloko OK, Salmon DA, Omer SB, Limaye RJ. Communicating Recommendations in Public Health Emergencies: The Role of Public Health Authorities. Health Secur 2020; 18(1): 21-8. PubMed Abstract.
  • Gostin LO, Salmon DA. The Dual Epidemics of COVID-19 and Influenza: Vaccine Acceptance, Coverage, and Mandates. Jama 2020; 324(4): 335-6. PubMed Abstract.
  • Dudley MZ, Privor-Dumm L, Dubé È, MacDonald NE. Words matter: Vaccine hesitancy, vaccine demand, vaccine confidence, herd immunity and mandatory vaccination. Vaccine 2020; 38(4): 709-11. PubMed Abstract.
  • Dudley MZ, Limaye RJ, Salmon DA, Omer SB, O’Leary ST, Ellingson MK, Spina CI, Brewer SE, Bednarczyk RA, Malik F, Frew PM, Chamberlain AT. Latent Class Analysis of Maternal Vaccine Attitudes and Beliefs. Health Educ Behav 2020; 47(5): 765-81. PubMed Abstract.
  • Dudley MZ, Limaye RJ, Omer SB, O’Leary ST, Ellingson MK, Spina CI, Brewer SE, Chamberlain AT, Bednarczyk RA, Malik F, Frew PM, Salmon DA. Characterizing the vaccine knowledge, attitudes, beliefs, and intentions of pregnant women in Georgia and Colorado. Hum Vaccin Immunother 2020; 16(5): 1109-17. PubMed Abstract.
  • Dudley MZ, Limaye RJ, Omer SB, O’Leary ST, Ellingson MK, Spina CI, Brewer SE, Chamberlain AT, Bednarczyk RA, Malik F, Frew PM, Salmon DA. Factors associated with referring close contacts to an app with individually-tailored vaccine information. Vaccine 2020; 38(13): 2827-32. PubMed Abstract.
  • Dudley MZ, Halsey NA, Omer SB, Orenstein WA, O’Leary ST, Limaye RJ, Salmon DA. The state of vaccine safety science: systematic reviews of the evidence. Lancet Infect Dis 2020; 20(5): e80-e9.  PubMed Abstract.
  • Delamater PL, Buttenheim AM, Klein NP, Mohanty S, Salmon DA, Omer SB. Assessment of Exemptions From Vaccination in California, 2015 to 2027. Ann Intern Med 2020; 172(5): 362-3.
  • Christianson MS, Wodi P, Talaat K, Halsey N. Primary ovarian insufficiency and human papilloma virus vaccines: a review of the current evidence. Am J Obstet Gynecol 2020; 222(3): 239-44. PubMed Abstract.
  • Carol Liu YC, Ibekwe T, Kelso JM, Klein NP, Shehu N, Steuerwald W, Aneja S, Dudley MZ, Garry R, Munoz FM. Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2020; 38(30): 4717-31. PubMed Abstract.
  • Bleser WK, Salmon DA, Miranda PY. A hidden vulnerable population: Young children up-to-date on vaccine series recommendations except influenza vaccines. PLoS One 2020; 15(6): e0234466.
  • Abuhegazy M, Talaat K, Anderoglu O, Poroseva SV. Numerical investigation of aerosol transport in a classroom with relevance to COVID-19. Phys Fluids (1994) 2020; 32(10): 103311. PubMed Abstract.

2019

  •  
  • Talaat KR, Bourgeois AL, Frenck RW, Chen WH, MacLennan CA, Riddle MS, Suvarnapunya AE, Brubaker JL, Kotloff KL, Porter CK. Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies. Clin Infect Dis. 2019 Dec 9;69(Supplement_8):S580-S590. doi: 10.1093/cid/ciz892. PubMed Abstract.
  • MacLennan CA, Riddle MS, Chen WH, Talaat KR, Jain V, Bourgeois AL, Frenck R, Kotloff K, Porter CK. Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints. Clin Infect Dis. 2019 Dec 9;69(Supplement_8):S591-S595. doi: 10.1093/cid/ciz891. PubMed Abstract.
  • Delamater PL, Buttenheim AM, Klein NP, Mohanty S, Salmon DA, Omer SB. Assessment of Exemptions From Vaccination in California, 2015 to 2027. Ann Intern Med. 2019 Nov 5. doi: 10.7326/M19-1933. [Epub ahead of print] PubMed Abstract.
  • Salmon DA, Limaye RJ, Dudley MZ, Oloko OK, Church-Balin C, Ellingson MK, Spina CI, Brewer SE, Orenstein WA, Halsey NA, Chamberlain AT, Bednarczyk RA, Malik FA, Frew PM, O’Leary ST, Omer SB. MomsTalkShots: An individually tailored educational application for maternal and infant vaccines. Vaccine. 2019 Oct 8;37(43):6478-6485. doi: 10.1016/j.vaccine.2019.08.080. Epub 2019 Sep 7. PubMed Abstract.
  • Hanevik K, Chen WH, Talaat KR, Porter C, Bourgeois L. The way forward for ETEC controlled human infection models (CHIMs). Vaccine. 2019 Aug 7;37(34):4794-4799. doi: 10.1016/j.vaccine.2019.01.003. Epub 2019 Jan 29. PubMed Abstract.
  • Pingali SC, Delamater PL, Buttenheim AM, Salmon DA, Klein NP, Omer SB. Associations of Statewide Legislative and Administrative Interventions With Vaccination Status Among Kindergartners in California. JAMA. 2019 Jul 2;322(1):49-56. doi: 10.1001/jama.2019.7924. PubMed Abstract.
  • Delamater PL, Pingali SC, Buttenheim AM, Salmon DA, Klein NP, Omer SB. Elimination of Nonmedical Immunization Exemptions in California and School-Entry Vaccine Status. Pediatrics. 2019 Jun;143(6). pii: e20183301. doi: 10.1542/peds.2018-3301. Epub 2019 May 21. PubMed Abstract.
  • Chamberlain AT, Limaye RJ, O’Leary ST, Frew PM, Brewer SE, Spina CI, Ellingson MK, Dudley MZ, Orenstein WA, Donnelly MA, Riley LE, Ault KA, Salmon DA, Omer SB. Development and acceptability of a video-based vaccine promotion tutorial for obstetric care providers. Vaccine. 2019 May 1;37(19):2532-2536. doi: 10.1016/j.vaccine.2019.03.005. Epub 2019 Apr 5. PubMed Abstract.
  • Bleser WK, Miranda PY, Salmon DA. Child Influenza Vaccination and Adult Work Loss: Reduced Sick Leave Use Only in Adults With Paid Sick Leave. Am J Prev Med. 2019 Feb;56(2):251-261. doi: 10.1016/j.amepre.2018.09.013. Epub 2018 Dec 17. PubMed Abstract.
  • Ellingson MK, Dudley MZ, Limaye RJ, Salmon DA, O’Leary ST, Omer SB. Enhancing uptake of influenza maternal vaccine. Expert Rev Vaccines. 2019 Feb;18(2):191-204. doi: 10.1080/14760584.2019.1562907. Epub 2019 Jan 28. Review. PubMed Abstract.
  • McDonald P, Limaye RJ, Omer SB, Buttenheim AM, Mohanty S, Klein NP, Salmon DA. Exploring California’s new law eliminating personal belief exemptions to childhood vaccines and vaccine decision-making among homeschooling mothers in California. Vaccine. 2019 Jan 29;37(5):742-750. doi: 10.1016/j.vaccine.2018.12.018. Epub 2019 Jan 6. PubMed Abstract.
  • Herman R, McNutt LA, Mehta M, Salmon DA, Bednarczyk RA, Shaw J. Vaccination perspectives among adolescents and their desired role in the decision-making process. Hum Vaccin Immunother. 2019;15(7-8):1752-1759. doi: 10.1080/21645515.2019.1571891. Epub 2019 Mar 14. PubMed Abstract.

2018

  •  
  • Bednarczyk RA, Chamberlain A, Mathewson K, Salmon DA, Omer SB. Practice-, Provider-, and Patient-level interventions to improve preventive care: Development of the P3 Model. Prev Med Rep. 2018 Jun 18;11:131-138. doi: 10.1016/j.pmedr.2018.06.009. eCollection 2018 Sep. PubMed Abstract.
  • Talaat KR, Halsey NA, Cox AB, Coles CL, Durbin AP, Ramakrishnan A, Bream JH. Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination. Influenza Other Respir Viruses. 2018 Mar;12(2):202-210. doi: 10.1111/irv.12509. Epub 2018 Jan 4. PubMed Abstract.

2017

  •  
  • Willis ED, Woodward M, Brown E, Popmihajlov Z, Saddier P, Annunziato PW, Halsey NA, Gershon AA. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience. Vaccine. 2017 Dec 19;35(52):7231-7239. doi: 10.1016/j.vaccine.2017.11.013. Epub 2017 Nov 22. Review. PubMed Abstract.
  • Omer SB, Porter RM, Allen K, Salmon DA, Bednarczyk RA. Trends in Kindergarten Rates of Vaccine Exemption and State-Level Policy, 2011-2016. Open Forum Infect Dis. 2017 Nov 15;5(2):ofx244. doi: 10.1093/ofid/ofx244. eCollection 2018 Feb. PubMed Abstract.
  • Halsey NA, Proveaux T. Value of an in-depth analysis of unpublished data on the safety of influenza vaccines in pregnant women. Vaccine. 2017 Oct 27;35(45):6154-6159. doi: 10.1016/j.vaccine.2017.09.049. Epub 2017 Sep 27. PubMed Abstract.
  • Shaw J, Halsey NA, Weinberg A, Scott Schmid D, George KS, Weldon WC, Jordan M, Bryant PW, LaRussa PS, Bradshaw DY, Harrington T, Gershon A. Arm Paralysis After Routine Childhood Vaccinations: Application of Advanced Molecular Methods to the Causality Assessment of an Adverse Event After Immunization. J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e161-e164. doi: 10.1093/jpids/piw084. PubMed Abstract.
  • Gessner BD, Halsey N. Dengue vaccine safety signal: Immune enhancement, waning immunity, or chance occurrence? Vaccine. 2017 Jun 14;35(27):3452-3456. doi: 10.1016/j.vaccine.2017.05.003. Epub 2017 May 18. PubMed Abstract.
  • Bednarczyk RA, Frew PM, Salmon DA, Whitney E, Omer SB. ReadyVax: A new mobile vaccine information app. Hum Vaccin Immunother. 2017 May 4;13(5):1149-1154. doi: 10.1080/21645515.2016.1263779. Epub 2017 Jan 6. PubMed Abstract.
  • Halsey NA. Reflections of a Vaccinologist: Lessons Learned About What We Can Do to Improve Trust in Vaccines and Vaccine Programsa. J Pediatric Infect Dis Soc. 2017 Mar 1;6(1):3-8. doi: 10.1093/jpids/piv077. PubMed Abstract.

2016

  •  
  • Proveaux T, Lambach P, Ortiz JR, Hombach J, Halsey NA. Review of prescribing information for influenza vaccines for pregnant and lactating women. Vaccine. 2016 Oct 26;34(45):5406-5409. doi: 10.1016/j.vaccine.2016.08.042. Epub 2016 Aug 29. Review. PubMed Abstract.
  • Talaat KR, Ellis RD, Hurd J, Hentrich A, Gabriel E, Hynes NA, Rausch KM, Zhu D, Muratova O, Herrera R, Anderson C, Jones D, Aebig J, Brockley S, MacDonald NJ, Wang X, Fay MP, Healy SA, Durbin AP, Narum DL, Wu Y, Duffy PE. Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults. PLoS One. 2016 Oct 17;11(10):e0163144. doi: 10.1371/journal.pone.0163144. eCollection 2016. PubMed Abstract.
  • Vadaparampil ST, Malo TL, Sutton SK, Ali KN, Kahn JA, Casler A, Salmon D, Walkosz B, Roetzheim RG, Zimet GD, Giuliano AR. Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males. Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1435-1446. Epub 2016 Aug 2. PubMed Abstract.
  • Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS, Edwards KM, Caubet JC, Engler RJ, Gold MS, Ponvert C, Demoly P, Sanchez-Borges M, Muraro A, Li JT, Rottem M, Rosenwasser LJ. International Consensus (ICON): allergic reactions to vaccines. World Allergy Organ J. 2016 Sep 16;9(1):32. doi: 10.1186/s40413-016-0120-5. eCollection 2016. PubMed Abstract.
  • Phadke VK, Bednarczyk RA, Salmon DA, Omer SB. Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis. JAMA. 2016 Mar 15;315(11):1149-58. doi: 10.1001/jama.2016.1353. Review. Erratum in: JAMA. 2016 May 17;315(19):2125. JAMA. 2016 May 17;315 (19):2125. PubMed Abstract.

2015

  •  
  • Halsey NA, Talaat KR, Greenbaum A, Mensah E, Dudley MZ, Proveaux T, Salmon DA. The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper. Vaccine. 2015 Dec 30;33 Suppl 5:F1-F67. doi: 10.1016/j.vaccine.2015.10.080. Review. PubMed Abstract.
  • Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine Hesitancy: Causes, Consequences, and a Call to Action. Am J Prev Med. 2015 Dec;49(6 Suppl 4):S391-8. doi: 10.1016/j.amepre.2015.06.009. Epub 2015 Aug 31. PubMed Abstract.
  • Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine hesitancy: Causes, consequences, and a call to action. Vaccine. 2015 Nov 27;33 Suppl 4:D66-71. doi: 10.1016/j.vaccine.2015.09.035. PubMed Abstract.
  • Vannice KS, Keita M, Sow SO, Durbin AP, Omer SB, Moulton LH, Yaméogo TM, Zuber PL, Onwuchekwa U, Sacko M, Diomandé FV, Halsey NA. Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali. Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S493-500. doi: 10.1093/cid/civ497. PubMed Abstract.

2014

  •  
  • Salmon DA. Pertussis resurgence and vaccine uptake: implications for reducing vaccine hesitancy. Pediatrics. 2014 Sep;134(3):602-4. doi: 10.1542/peds.2014-1883. PubMed Abstract.
  • Hofstetter AM, Jakob K, Klein NP, Dekker CL, Edwards KM, Halsey NA, Baxter R, Williams SE, Graham PL 3rd, LaRussa P. Live vaccine use and safety in DiGeorge syndrome. Pediatrics. 2014 Apr;133(4):e946-54. doi: 10.1542/peds.2013-0831. Epub 2014 Mar 31. PubMed Abstract.
  • Vadaparampil ST, Malo TL, Kahn JA, Salmon DA, Lee JH, Quinn GP, Roetzheim RG, Bruder KL, Proveaux TM, Zhao X, Halsey NA, Giuliano AR. Physicians’ human papillomavirus vaccine recommendations, 2009 and 2011. Am J Prev Med. 2014 Jan;46(1):80-4. doi: 10.1016/j.amepre.2013.07.009. PubMed Abstract.
  • Halsey NA, Griffioen M, Dreskin SC, Dekker CL, Wood R, Sharma D, Jones JF, LaRussa PS, Garner J, Berger M, Proveaux T, Vellozzi C; Hypersensitivity Working Group of the Clinical Immunization Safety Assessment Network, Broder K, Setse R, Pahud B, Hrncir D, Choi H, Sparks R, Williams SE, Engler RJ, Gidudu J, Baxter R, Klein N, Edwards K, Cano M, Kelso JM. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS. Vaccine. 2013 Dec 9;31(51):6107-12. doi: 10.1016/j.vaccine.2013.09.066. Epub 2013 Oct 8. PubMed Abstract.
  • Asturias EJ, Contreras-Roldan IL, Ram M, Garcia-Melgar AJ, Morales-Oquendo V, Hartman K, Rauscher M, Moulton LH, Halsey NA. Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children. Vaccine. 2013 Dec 2;31(49):5909-14. doi: 10.1016/j.vaccine.2013.09.015. Epub 2013 Sep 19. PubMed Abstract.
  • Tozzi AE, Asturias EJ, Balakrishnan MR, Halsey NA, Law B, Zuber PL. Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use. Vaccine. 2013 Oct 17;31(44):5041-6. doi: 10.1016/j.vaccine.2013.08.087. Epub 2013 Sep 8. PubMed Abstract.
  • Mergler MJ, Omer SB, Pan WK, Navar-Boggan AM, Orenstein W, Marcuse EK, Taylor J, DeHart MP, Carter TC, Damico A, Halsey N, Salmon DA. Association of vaccine-related attitudes and beliefs between parents and health care providers. Vaccine. 2013 Sep 23;31(41):4591-5. doi: 10.1016/j.vaccine.2013.07.039. Epub 2013 Jul 27. PubMed Abstract.
  • Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H; Global H1N1 GBS Consortium. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013 Sep 13;31(40):4448-58. doi: 10.1016/j.vaccine.2013.06.032. Epub 2013 Jun 14. PubMed Abstract.
  • Williams SE, Edwards KM, Baxter RP, LaRussa PS, Halsey NA, Dekker CL, Vellozzi C, Marchant CD, Donofrio PD, Reimschisel TE, Berger M, Gidudu JF, Klein NP. Comprehensive assessment of serious adverse events following immunization by health care providers. J Pediatr. 2013 Jun;162(6):1276-81, 1281.e1. doi: 10.1016/j.jpeds.2013.01.028. Epub 2013 Feb 26. PubMed Abstract.
  • Grant L, Watt J, Moulton L, Weatherholtz R, Reid R, Santosham M, O’Brien K. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine. J Pediatr Gastroenterol Nutr. 2013 Jun;56(6):635-40. doi: 10.1097/MPG.0b013e318287c5cc. PubMed Abstract.
  • Mergler MJ, Omer SB, Pan WK, Navar-Boggan AM, Orenstein W, Marcuse EK, Taylor J, deHart MP, Carter TC, Damico A, Halsey N, Salmon DA. Are Recent Medical Graduates More Skeptical of Vaccines? Vaccines (Basel). 2013 Apr 29;1(2):154-66. doi: 10.3390/vaccines1020154. PubMed Abstract.
  • Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13. PubMed Abstract.
  • Durbin AP, Kirkpatrick BD, Pierce KK, Elwood D, Larsson CJ, Lindow JC, Tibery C, Sabundayo BP, Shaffer D, Talaat KR, Hynes NA, Wanionek K, Carmolli MP, Luke CJ, Murphy BR, Subbarao K, Whitehead SS. A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial. J Infect Dis. 2013 Mar 15;207(6):957-65. doi: 10.1093/infdis/jis936. Epub 2013 Jan 17. PubMed Abstract.
  • Pahud BA, Williams SE, Dekker CL, Halsey N, Larussa P, Baxter RP, Klein NP, Marchant CD, Sparks RC, Jakob K, Aukes L, Swope S, Barnett E, Lewis P, Berger M, Dreskin SC, Donofrio PD, Sejvar JJ, Slade BA, Gidudu J, Vellozzi C, Edwards KM. Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination. Pediatr Infect Dis J. 2013 Feb;32(2):163-8. doi: 10.1097/INF.0b013e318271b90a. PubMed Abstract.

2012

  •  
  • Talaat KR, Karron RA, Liang PH, McMahon BA, Luke CJ, Thumar B, Chen GL, Min JY, Lamirande EW, Jin H, Coelingh KL, Kemble GW, Subbarao K. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults. Influenza Other Respir Viruses. 2013 Jan;7(1):66-73. doi: 10.1111/j.1750-2659.2012.00350.x. Epub 2012 Mar 14. PubMed Abstract.
  • Rowhani-Rahbar A, Klein NP, Dekker CL, Edwards KM, Marchant CD, Vellozzi C, Fireman B, Sejvar JJ, Halsey NA, Baxter R; Risk Interval Working Group of the Clinical Immunization Safety Assessment Network. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine. 2012 Dec 17;31(1):271-7. doi: 10.1016/j.vaccine.2012.07.024. Epub 2012 Jul 24. Review. PubMed Abstract.
  • Salmon D, Yih WK, Lee G, Rosofsky R, Brown J, Vannice K, Tokars J, Roddy J, Ball R, Gellin B, Lurie N, Koh H, Platt R, Lieu T; PRISM Program Group. Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance. Health Aff (Millwood). 2012 Nov;31(11):2518-27. doi: 10.1377/hlthaff.2012.0104. PubMed Abstract.
  • Halsey NA, Edwards KM, Dekker CL, Klein NP, Baxter R, Larussa P, Marchant C, Slade B, Vellozzi C; Causality Working Group of the Clinical Immunization Safety Assessment network. Algorithm to assess causality after individual adverse events following immunizations. Vaccine. 2012 Aug 24;30(39):5791-8. Epub 2012 Apr 14. PubMed Abstract.
  • Sullender W, Fowler K, Krishnan A, Gupta V, Moulton LH, Lafond K, Widdowson MA, Lal RB, Broor S. Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India. Vaccine. 2012 Jul 27;30(35):5235-9. doi: 10.1016/j.vaccine.2012.06.002. Epub 2012 Jun 16. PubMed Abstract.
  • Yih WK, Lee GM, Lieu TA, Ball R, Kulldorff M, Rett M, Wahl PM, McMahill-Walraven CN, Platt R, Salmon DA. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. Am J Epidemiol. 2012 Jun 1;175(11):1120-8. doi: 10.1093/aje/kws197. Epub 2012 May 11. PubMed Abstract.
  • Scott JR, Hanage WP, Lipsitch M, Millar EV, Moulton LH, Hinds J, Reid R, Santosham M, O’Brien KL. Pneumococcal sequence type replacement among American Indian children: a comparison of pre- and routine-PCV7 eras. Vaccine. 2012 Mar 16;30(13):2376-81. doi: 10.1016/j.vaccine.2011.11.004. Epub 2011 Nov 15. PubMed Abstract.
  • Grant LR, Watt JP, Weatherholtz RC, Moulton LH, Reid R, Santosham M, O’Brien KL. Efficacy of a pentavalent human-bovine reassortant rotavirus vaccine against rotavirus gastroenteritis among American Indian children. Pediatr Infect Dis J. 2012 Feb;31(2):184-8. doi: 10.1097/INF.0b013e3182435afe. PubMed Abstract.
  • Jones AM, Omer SB, Bednarczyk RA, Halsey NA, Moulton LH, Salmon DA. Parents’ source of vaccine information and impact on vaccine attitudes, beliefs, and nonmedical exemptions. Adv Prev Med. 2012;2012:932741. doi: 10.1155/2012/932741. Epub 2012 Oct 2. PubMed Abstract.

2011

  •  
  • Williams SE, Pahud BA, Vellozzi C, Donofrio PD, Dekker CL, Halsey N, Klein NP, Baxter RP, Marchant CD, Larussa PS, Barnett ED, Tokars JI, McGeeney BE, Sparks RC, Aukes LL, Jakob K, Coronel S, Sejvar JJ, Slade BA, Edwards KM. Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. Vaccine. 2011 Oct 26;29(46):8302-8. doi: 10.1016/j.vaccine.2011.08.093. Epub 2011 Sep 3. PubMed Abstract.
  • Williams SE, Klein NP, Halsey N, Dekker CL, Baxter RP, Marchant CD, LaRussa PS, Sparks RC, Tokars JI, Pahud BA, Aukes L, Jakob K, Coronel S, Choi H, Slade BA, Edwards KM. Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009. Vaccine. 2011 Sep 16;29(40):6920-7. doi: 10.1016/j.vaccine.2011.07.044. Epub 2011 Jul 27. Review. PubMed Abstract.
  • Salmon DA, Akhtar A, Mergler MJ, Vannice KS, Izurieta H, Ball R, Lee GM, Vellozzi C, Garman P, Cunningham F, Gellin B, Koh H, Lurie N; H1N1 Working Group of Federal Immunization Safety Task Force. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics. 2011 May;127 Suppl 1:S78-86. doi: 10.1542/peds.2010-1722L. Epub 2011 Apr 18. Review. PubMed Abstract.
  • Vannice KS, Salmon DA, Shui I, Omer SB, Kissner J, Edwards KM, Sparks R, Dekker CL, Klein NP, Gust DA. Attitudes and beliefs of parents concerned about vaccines: impact of timing of immunization information. Pediatrics. 2011 May;127 Suppl 1:S120-6. doi: 10.1542/peds.2010-1722R. Epub 2011 Apr 18. PubMed Abstract.
  • Salmon DA, Pavia A, Gellin B. Editors’ introduction: Vaccine safety throughout the product life cycle. Pediatrics. 2011 May;127 Suppl 1:S1-4. doi: 10.1542/peds.2010-1722U. Epub 2011 Apr 18. PubMed Abstract.
  • LaRussa PS, Edwards KM, Dekker CL, Klein NP, Halsey NA, Marchant C, Baxter R, Engler RJ, Kissner J, Slade BA. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network. Pediatrics. 2011 May;127 Suppl 1:S65-73. doi: 10.1542/peds.2010-1722J. Epub 2011 Apr 18. PubMed Abstract.
  • Hussain H, Omer SB, Manganello JA, Kromm EE, Carter TC, Kan L, Stokley S, Halsey NA, Salmon DA. Immunization safety in US print media, 1995-2005. Pediatrics. 2011 May;127 Suppl 1:S100-6. doi: 10.1542/peds.2010-1722O. Epub 2011 Apr 18. PubMed Abstract.
  • Talaat KR, Karron RA, Luke CJ, Thumar B, McMahon BA, Chen GL, Lamirande EW, Jin H, Coelingh KL, Kemble G, Subbarao K. An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. Vaccine. 2011 Apr 12;29(17):3144-8. doi: 10.1016/j.vaccine.2011.02.043. Epub 2011 Mar 4. PubMed Abstract.
  • Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M; Brighton Collaboration GBS Working Group. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011 Jan 10;29(3):599-612. doi: 10.1016/j.vaccine.2010.06.003. Epub 2010 Jun 18. Review. PubMed Abstract.
  • Shen AK, Spinner JR, Salmon DA, Gellin BG. Strengthening the U.S. vaccine and immunization enterprise: the role of the National Vaccine Advisory Committee. Public Health Rep. 2011 Jan-Feb;126(1):4-8. PubMed Abstract.

2010

  •  
  • Salmon DA. The association between intentional delay of vaccine administration and timely childhood vaccination coverage. Public Health Rep. 2010 Jul-Aug;125(4):534-41. PubMed Abstract.
  • Black S, Mulholland K, Halsey NA. Developing sustainable funding for vaccine safety infrastructure. Vaccine. 2010 Feb 3;28(5):1133-4. doi: 10.1016/j.vaccine.2009.11.034. Epub 2009 Nov 27. Review. PubMed Abstract.

2009

  •  
  • Halsey N, MacDonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet. 2009 Dec 19;374(9707):2115-2122. doi: 10.1016/S0140-6736(09)61877-8. Epub 2009 Oct 31. Erratum in: Lancet. 2010 Jan 30;375(9712):376. PubMed Abstract.
  • Tamma PD, Ault KA, del Rio C, Steinhoff MC, Halsey NA, Omer SB. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol. 2009 Dec;201(6):547-52. doi: 10.1016/j.ajog.2009.09.034. Epub 2009 Oct 21. Review. PubMed Abstract.
  • Bogdanovic J, Halsey NA, Wood RA, Hamilton RG. Bovine and porcine gelatin sensitivity in children sensitized to milk and meat. J Allergy Clin Immunol. 2009 Nov;124(5):1108-10. doi: 10.1016/j.jaci.2009.06.021. Epub 2009 Aug 8. PubMed Abstract.
  • Durbin AP, Setse R, Omer SB, Palmer JG, Spaeder JA, Baker J, Lessans F, Halsey NA. Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system. Vaccine. 2009 Oct 19;27(44):6143-7. doi: 10.1016/j.vaccine.2009.08.024. Epub 2009 Aug 25. PubMed Abstract.
  • Karron RA, Talaat K, Luke C, Callahan K, Thumar B, Dilorenzo S, McAuliffe J, Schappell E, Suguitan A, Mills K, Chen G, Lamirande E, Coelingh K, Jin H, Murphy BR, Kemble G, Subbarao K. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine. 2009 Aug 6;27(36):4953-60. doi: 10.1016/j.vaccine.2009.05.099. Epub 2009 Jun 21. PubMed Abstract.
  • Salmon DA, Smith PJ, Pan WK, Navar AM, Omer SB, Halsey NA. Disparities in preschool immunization coverage associated with maternal age. Hum Vaccin. 2009 Aug;5(8):557-61. Epub 2009 Aug 14. PubMed Abstract.
  • Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR, Kemble G, Subbarao K. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine. 2009 Jun 8;27(28):3744-53. doi: 10.1016/j.vaccine.2009.03.082. Epub 2009 Apr 17. PubMed Abstract.
  • Asturias EJ, Mayorga C, Caffaro C, Ramirez P, Ram M, Verstraeten T, Clemens R, Halsey NA. Differences in the immune response to hepatitis B and Haemophilus influenzae type b vaccines in Guatemalan infants by ethnic group and nutritional status. Vaccine. 2009 Jun 2;27(27):3650-4. doi: 10.1016/j.vaccine.2009.03.035. Epub 2009 Apr 7. PubMed Abstract.
  • Salmon DA, Sotir MJ, Pan WK, Berg JL, Omer SB, Stokley S, Hopfensperger DJ, Davis JP, Halsey NA. Parental vaccine refusal in Wisconsin: a case-control study. WMJ. 2009 Feb;108(1):17-23. PubMed Abstract.

2008

  •  
  • Noazin S, Modabber F, Khamesipour A, Smith PG, Moulton LH, Nasseri K, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Kieny MP, Tanner M. First generation leishmaniasis vaccines: a review of field efficacy trials. Vaccine. 2008 Dec 9;26(52):6759-67. doi: 10.1016/j.vaccine.2008.09.085. Epub 2008 Oct 23. Review. PubMed Abstract.
  • Kohl KS, Magnus M, Ball R, Halsey N, Shadomy S, Farley TA. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization. Vaccine. 2008 Nov 25;26(50):6349-60. doi: 10.1016/j.vaccine.2008.09.002. Epub 2008 Sep 19. PubMed Abstract.
  • Launay O, Grabar S, Gordien E, Desaint C, Jegou D, Abad S, Girard PM, Bélarbi L, Guérin C, Dimet J, Williams V, Krivine A, Salmon D, Lortholary O, Rey D; HEPAVAC Study Group1. Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study. J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):272-5. doi: 10.1097/QAI.0b013e318183a9c0. PubMed Abstract.
  • Halsey NA. The human papillomavirus vaccine and risk of anaphylaxis. CMAJ. 2008 Sep 9;179(6):509-10. doi: 10.1503/cmaj.081133. Epub 2008 Sep 1. Erratum in: CMAJ. 2008 Sep 23;179(7):678. PubMed Abstract.
  • Wood RA, Berger M, Dreskin SC, Setse R, Engler RJ, Dekker CL, Halsey NA; Hypersensitivity Working Group of the Clinical Immunization Safety Assessment (CISA) Network. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics. 2008 Sep;122(3):e771-7. doi: 10.1542/peds.2008-1002. PubMed Abstract.
  • Salmon DA, Pan WK, Omer SB, Navar AM, Orenstein W, Marcuse EK, Taylor J, deHart MP, Stokley S, Carter T, Halsey NA. Vaccine knowledge and practices of primary care providers of exempt vs. vaccinated children. Hum Vaccin. 2008 Jul-Aug;4(4):286-91. Epub 2008 Feb 19. PubMed Abstract.

2007

  •  
  • Vernick JS, Rutkow L, Salmon DA. Availability of litigation as a public health tool for firearm injury prevention: comparison of guns, vaccines, and motor vehicles. Am J Public Health. 2007 Nov;97(11):1991-7. Epub 2007 Sep 27. PubMed Abstract.
  • Návar AM, Halsey NA, Carter TC, Montgomery MP, Salmon DA. Prenatal immunization education the pediatric prenatal visit and routine obstetric care. Am J Prev Med. 2007 Sep;33(3):211-3. PubMed Abstract.
  • Launay O, Durier C, Desaint C, Silbermann B, Jackson A, Pialoux G, Bonnet B, Poizot-Martin I, Gonzalez-Canali G, Cuzin L, Figuereido S, Surenaud M, Ben Hamouda N, Gahery H, Choppin J, Salmon D, Guérin C, Bourgault Villada I, Guillet JG; ANRS VAC16 Study Group. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. PLoS One. 2007 Aug 22;2(8):e725. PubMed Abstract.
  • Wood RA, Setse R, Halsey N; Clinical Immunization Safety Assessment (CISA) Network Hypersensitivity Working Group. Irritant skin test reactions to common vaccines. J Allergy Clin Immunol. 2007 Aug;120(2):478-81. Epub 2007 Jun 4. PubMed Abstract.

2006

  •  
  • Halsey NA. Measles in developing countries. BMJ. 2006 Dec 16;333(7581):1234. PubMed Abstract.
  • Omer SB, Pan WK, Halsey NA, Stokley S, Moulton LH, Navar AM, Pierce M, Salmon DA. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA. 2006 Oct 11;296(14):1757-63. PubMed Abstract.
  • Linkins RW, Salmon DA, Omer SB, Pan WK, Stokley S, Halsey NA. Support for immunization registries among parents of vaccinated and unvaccinated school-aged children: a case control study. BMC Public Health. 2006 Sep 22;6:236. PubMed Abstract.
  • Khan AJ, Gebreselassie H, Asturias EJ, Agboatwalla M, Teklehaimanot R, Luby SP, Beyene B, Chezzi C, Asghar H, Moatter T, Torres OR, Kew O, Winkelstein J, Halsey NA. No evidence for prolonged excretion of polioviruses in persons with residual paralytic poliomyelitis in Ethiopia, Pakistan and Guatemala. Biologicals. 2006 Jun;34(2):113-6. Epub 2006 May 8. Erratum in: Biologicals. 2007 Mar;35(1):73. Bayene, Berhane [corrected to Beyene, Berhane]. PubMed Abstract.
  • Modlin JF, Halsey NA. Excretion of oral poliovirus vaccine strains: effect of vaccination schedule. J Infect Dis. 2006 Jun 1;193(11):1614-5. PubMed Abstract.
  • Durier C, Launay O, Meiffrédy V, Saïdi Y, Salmon D, Lévy Y, Guillet JG, Pialoux G, Aboulker JP. Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults. AIDS. 2006 Apr 24;20(7):1039-49. PubMed Abstract.
  • Salmon DA, Teret SP, MacIntyre CR, Salisbury D, Burgess MA, Halsey NA. Compulsory vaccination and conscientious or philosophical exemptions: past, present, and future. Lancet. 2006 Feb 4;367(9508):436-42. Review. PubMed Abstract.
  • Salmon DA, Smith PJ, Navar AM, Pan WK, Omer SB, Singleton JA, Halsey NA. Measuring immunization coverage among preschool children: past, present, and future opportunities. Epidemiol Rev. 2006;28:27-40. Epub 2006 Jun 1. Review. PubMed Abstract.

2005

  •  
  • Moulton LH, Rahmathullah L, Halsey NA, Thulasiraj RD, Katz J, Tielsch JM. Evaluation of non-specific effects of infant immunizations on early infant mortality in a southern Indian population. Trop Med Int Health. 2005 Oct;10(10):947-55. PubMed Abstract.
  • Salmon DA, Sapsin JW, Teret S, Jacobs RF, Thompson JW, Ryan K, Halsey NA. Public health and the politics of school immunization requirements. Am J Public Health. 2005 May;95(5):778-83. Review. PubMed Abstract.
  • Salmon DA, Moulton LH, Omer SB, DeHart MP, Stokley S, Halsey NA. Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study. Arch Pediatr Adolesc Med. 2005 May;159(5):470-6. PubMed Abstract.
  • MacIntyre CR, Kelly H, Jolley D, Butzkueven H, Salmon D, Halsey N, Moulton LH. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology. 2005 Apr 12;64(7):1317; author reply 1318. PubMed Abstract.
  • Salmon DA, Omer SB, Moulton LH, Stokley S, Dehart MP, Lett S, Norman B, Teret S, Halsey NA. Exemptions to school immunization requirements: the role of school-level requirements, policies, and procedures. Am J Public Health. 2005 Mar;95(3):436-40. Erratum in: Am J Public Health. 2005 Apr;95(4):551. PubMed Abstract.

2004

  •  
  • Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, Ward BJ, West DJ. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):825-40. Review. PubMed Abstract.
  • Kalies H, Verstraeten T, Grote V, Meyer N, Siedler A, Schmitt HJ, Breuer T, Moulton LH, von Kries R; Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland Study Group. Four and one-half-year follow-up of the effectiveness of diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b and diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus/H. influenzae type b combination vaccines in Germany. Pediatr Infect Dis J. 2004 Oct;23(10):944-50. PubMed Abstract.
  • Salmon DA, Moulton LH, Halsey NA. Enhancing public confidence in vaccines through independent oversight of postlicensure vaccine safety. Am J Public Health. 2004 Jun;94(6):947-50. PubMed Abstract.
  • Salmon DA, Moulton LH, Omer SB, Chace LM, Klassen A, Talebian P, Halsey NA. Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions. Pediatrics. 2004 Jun;113(6):e552-9. PubMed Abstract.
  • Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA. 2004 May 5;291(17):2086-91. PubMed Abstract.
  • Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004 May 1;189 Suppl 1:S4-16. Review. PubMed Abstract.
  • Rothstein E, Kohl KS, Ball L, Halperin SA, Halsey N, Hammer SJ, Heath PT, Hennig R, Kleppinger C, Labadie J, Varricchio F, Vermeer P, Walop W; Brighton Collaboration Local Reaction Working Group. Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine. 2004 Jan 26;22(5-6):575-85. Review. PubMed Abstract.
  • Bonhoeffer J, Menkes J, Gold MS, de Souza-Brito G, Fisher MC, Halsey N, Vermeer P; Brighton Collaboration Seizure Working Group. Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine. 2004 Jan 26;22(5-6):557-62. Review. PubMed Abstract.
  • Halsey NA, Pinto J, Espinosa-Rosales F, Faure-Fontenla MA, da Silva E, Khan AJ, Webster AD, Minor P, Dunn G, Asturias E, Hussain H, Pallansch MA, Kew OM, Winkelstein J, Sutter R; Polio Project Team. Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. Bull World Health Organ. 2004 Jan;82(1):3-8. PubMed Abstract.

2003

  •  
  • Asturias EJ, Soto M, Menendez R, Ramirez PL, Recinos F, Gordillo R, Holt E, Halsey NA. Meningitis and pneumonia in Guatemalan children: the importance of Haemophilus influenzae type b and Streptococcus pneumoniae. Rev Panam Salud Publica. 2003 Dec;14(6):377-84. PubMed Abstract.
  • O’Brien KL, Moulton LH, Reid R, Weatherholtz R, Oski J, Brown L, Kumar G, Parkinson A, Hu D, Hackell J, Chang I, Kohberger R, Siber G, Santosham M. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet. 2003 Aug 2;362(9381):355-61. PubMed Abstract.
  • Bartlett J, Borio L, Radonovich L, Mair JS, O’Toole T, Mair M, Halsey N, Grow R, Inglesby TV. Smallpox vaccination in 20key information for clinicians. Clin Infect Dis. 2003 Apr 1;36(7):883-902. Epub 2003 Mar 18. PubMed Abstract.
  • Halsey NA. Commentary: poliomyelitis and unnecessary injections. Int J Epidemiol. 2003 Apr;32(2):278-9. PubMed Abstract.
  • Moss WJ, Clements CJ, Halsey NA. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ. 2003;81(1):61-70. Epub 2003 Mar 11. Review. PubMed Abstract.
  • Halsey N, Rose N. Questions and answers about autoimmunity and the smallpox vaccine. Isr Med Assoc J. 2003 Jan;5(1):40-1. PubMed Abstract.
  • Furth SL, Hogg RJ, Tarver J, Moulton LH, Chan C, Fivush BA; Southwest Pediatric Nephrology Study Group. Varicella vaccination in children with chronic renal failure. A report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol. 2003 Jan;18(1):33-8. Epub 2002 Nov 22. PubMed Abstract.

2002

  •  
  • Ball R, Halsey N, Braun MM, Moulton LH, Gale AD, Rammohan K, Wiznitzer M, Johnson R, Salive ME; VAERS Working Group. Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the vaccine: Adverse Event Reporting System. J Clin Epidemiol. 2002 Aug;55(8):819-24. PubMed Abstract.
  • Halsey NA. The science of evaluation of adverse events associated with vaccination. Semin Pediatr Infect Dis. 2002 Jul;13(3):205-14. Review. PubMed Abstract.
  • Halsey NA. The need for immunoglobulin for travelers who receive hepatitis A vaccine. Pediatr Infect Dis J. 2002 Jun;21(6):576-7. PubMed Abstract.
  • Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ; Anthrax Vaccine Export Committee. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):189-202. Review. PubMed Abstract.
  • Halsey NA. Anthrax vaccine and causality assessment from individual case reports. Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):185-7; discussion 203-4. PubMed Abstract.
  • Leitch R, Halsey N, Hyman SL. MMR–Separate administration-has it been done? Pediatrics. 2002 Jan;109(1):172. PubMed Abstract.

2001

  •  
  • Halsey NA. Combination vaccines: defining and addressing current safety concerns. Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S312-8. Review. PubMed Abstract.
  • Halsey NA. Safety of combination vaccines: perception versus reality. Pediatr Infect Dis J. 2001 Nov;20(11 Suppl):S40-4. Review. PubMed Abstract.
  • Moulton LH, O’Brien KL, Kohberger R, Chang I, Reid R, Weatherholtz R, Hackell JG, Siber GR, Santosham M. Design of a group-randomized Streptococcus pneumoniae vaccine trial. Control Clin Trials. 2001 Aug;22(4):438-52. PubMed Abstract.
  • Halsey NA, Goldman L. Balancing risks and benefits: Primum non nocere is too simplistic. Pediatrics. 2001 Aug;108(2):466-7. PubMed Abstract.
  • Sikand VK, Halsey N, Krause PJ, Sood SK, Geller R, Van Hoecke C, Buscarino C, Parenti D; Pediatric Lyme Vaccine Study Group. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial. Pediatrics. 2001 Jul;108(1):123-8. PubMed Abstract.
  • Halsey NA, Hyman SL; Conference Writing Panel. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000. Pediatrics. 2001 May;107(5):E84. Review. PubMed Abstract.

2000

  •  
  • Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA. 2000 Dec 27;284(24):3145-50. PubMed Abstract.
  • Moulton LH, Chung S, Croll J, Reid R, Weatherholtz RC, Santosham M. Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population. Int J Epidemiol. 2000 Aug;29(4):753-6. PubMed Abstract.
  • Qureshi H, Gessner BD, Leboulleux D, Hasan H, Alam SE, Moulton LH. The incidence of vaccine preventable influenza-like illness and medication use among Pakistani pilgrims to the Haj in Saudi Arabia. Vaccine. 2000 Jul 1;18(26):2956-62. PubMed Abstract.

1999

  •  
  • Halsey NA. Limiting infant exposure to thimerosal in vaccines and other sources of mercury. JAMA. 1999 Nov 10;282(18):1763-6. PubMed Abstract.
  • Salmon DA, Haber M, Gangarosa EJ, Phillips L, Smith NJ, Chen RT. Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA. 1999 Jul 7;282(1):47-53. Erratum in: JAMA 2000 May 3;283(17):2241. PubMed Abstract.
  • Childhood immunizations and type 1 diabetes: summary of an Institute for Vaccine Safety Workshop. The Institute for Vaccine Safety Diabetes Workshop Panel. Pediatr Infect Dis J. 1999 Mar;18(3):217-22. Review. PubMed Abstract.
  • Halsey NA, Duclos P, Van Damme P, Margolis H. Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board. Pediatr Infect Dis J. 1999 Jan;18(1):23-4. Review. PubMed Abstract.

Contents